Piard J, Aral B, Vabres P, Holder-Espinasse M, Mégarbané A, Gauthier S, Capra V, Pierquin G, Callier P, Baumann C, Pasquier L, Baujat G, Martorell L, Rodriguez A, Brady A F, Boralevi F, González-Enseñat M A, Rio M, Bodemer C, Philip N, Cordier M-P, Goldenberg A, Demeer B, Wright M, Blair E, Puzenat E, Parent P, Sznajer Y, Francannet C, DiDonato N, Boute O, Barlogis V, Moldovan O, Bessis D, Coubes C, Tardieu M, Cormier-Daire V, Sousa A B, Franques J, Toutain A, Tajir M, Elalaoui S C, Geneviève D, Thevenon J, Courcet J-B, Rivière J-B, Collet C, Gigot N, Faivre L, Thauvin-Robinet C
EA 4271 GAD "Génétique des Anomalies du Développement", IFR Santé STIC, Université de Bourgogne, Dijon, France; Centre de Génétique Humaine, CHU Besançon, Besançon, France.
Clin Genet. 2015 Mar;87(3):244-51. doi: 10.1111/cge.12361. Epub 2014 Mar 26.
Three overlapping conditions, namely Rothmund-Thomson (RTS), Baller-Gerold (BGS) and RAPADILINO syndromes, have been attributed to RECQL4 mutations. Differential diagnoses depend on the clinical presentation, but the numbers of known genes remain low, leading to the widespread prescription of RECQL4 sequencing. The aim of our study was therefore to determine the best clinical indicators for the presence of RECQL4 mutations in a series of 39 patients referred for RECQL4 molecular analysis and belonging to the RTS (27 cases) and BGS (12 cases) spectrum. One or two deleterious RECQL4 mutations were found in 10/27 patients referred for RTS diagnosis. Clinical and molecular reevaluation led to a different diagnosis in 7/17 negative cases, including Clericuzio-type poikiloderma with neutropenia, hereditary sclerosing poikiloderma, and craniosynostosis/anal anomalies/porokeratosis. No RECQL4 mutations were found in the BGS group without poikiloderma, confirming that RECQL4 sequencing was not indicated in this phenotype. One chromosomal abnormality and one TWIST mutation was found in this cohort. This study highlights the search for differential diagnoses before the prescription of RECQL4 sequencing in this clinically heterogeneous group. The combination of clinically defined subgroups and next-generation sequencing will hopefully bring to light new molecular bases of syndromes with poikiloderma, as well as BGS without poikiloderma.
三种重叠病症,即罗思蒙德-汤姆森(RTS)综合征、巴勒-杰罗尔德(BGS)综合征和拉帕迪利诺综合征,已被归因于RECQL4基因突变。鉴别诊断取决于临床表现,但已知基因数量仍然较少,这导致RECQL4测序被广泛应用。因此,我们研究的目的是在39例因RECQL4分子分析而转诊的患者中确定RECQL4突变存在的最佳临床指标,这些患者属于RTS(27例)和BGS(12例)谱系。在转诊进行RTS诊断的27例患者中,10例发现了一到两个有害的RECQL4突变。临床和分子重新评估导致17例阴性病例中的7例有了不同诊断,包括伴有中性粒细胞减少的克莱里库齐奥型皮肤异色症、遗传性硬化性皮肤异色症以及颅缝早闭/肛门异常/汗孔角化病。在无皮肤异色症的BGS组中未发现RECQL4突变,证实该表型无需进行RECQL4测序。在该队列中发现了1例染色体异常和1例TWIST突变。本研究强调在这个临床异质性群体中,在进行RECQL4测序之前要进行鉴别诊断。临床定义的亚组与下一代测序相结合,有望揭示伴有皮肤异色症的综合征以及无皮肤异色症的BGS综合征的新分子基础。